ALB and diabetic retinopathy: Ischemia modified albumin (IMA) has emerged as a novel and inexpensive biomarker for assessing ischemia and oxidative stress in diabetic retinopathy.9,10 IMA is a structurally modified form of albumin that results from ischemia and the consequent oxidative stress (OXS) and free radicals.